ITS

A more powerful way to test skin sensitisation

More accurate, reproducible risk assessment to determine whether a substance is a skin sensitiser

"Detailed Report” feature for SkinSens ITS

Following the successful SkinSens ITS release during the Society of Toxicology annual meeting 2017, we received plenty of positive feedback and valuable suggestions for additional features.

Skin Sensitization Application

Allergic contact dermatitis (aka., skin sensitization) accounts for 20% of all contact dermatitis cases and hence has an estimated annual cost up to $200 million. It is also a public health problem...

About Douglas Connect

Douglas Connect manages collaborative projects to achieve goals in scientific research, infrastructure development or service provision. Effective collaboration requires many elements including coordination, culture, communications, common understanding, decision-making and interoperability.

Latest Tweets

Douglas Connect (Yesterday)
New Risk Assessment app brings data together - read about our new app here: https://t.co/aIL7uFPllV …… https://t.co/cJrkj8lC70
Douglas Connect (6 days ago)
InnovationWell comes to Basel, OpenRiskNet launches its new website, read the November 2018 Douglas Connect Newslet… https://t.co/VJ4Eg3pH9a
Douglas Connect (2 weeks ago)
Could modern information technology provide the missing link to make full use of the hundreds of thousands of compo… https://t.co/2jop0bnxmA
Douglas Connect (4 weeks ago)
RT @LucianFarcal: Learning on EU open #PM2 methodology @EURACADEMY projects implementation process, benefits for the organisation and socie…
Douglas Connect (4 weeks ago)
Exploring AI and Machine Learning Approaches to Precision Medicine and Healthcare - Webinar 2:30-3:30 pm EDT, Thurs… https://t.co/h8z8NSpxB8

Get in touch

  • Address: Douglas Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland
  • Phone: +41 61 851 0170
  • Email: info@douglasconnect.com